Chronic Myelogenous Leukemia in Adults

We conduct sophisticated diagnostic tests such as chromosomal analysis to identify chronic myelogenous leukemia, a slow-growing cancer of the bone marrow and blood. We offer targeted chemotherapy that helps some people achieve long-term remission, in which cancer cells are no longer detected in the body. Stem cell transplantation is available for more aggressive cancer. We also provide psychosocial support to help you thrive during treatment for this chronic condition.

Clinical Trials and Research Studies

Phase 6

AALL1931: JZP458-201: An Open Label Multicenter Study of RC-P in Patients with Acute Lymphoblastic Leukemia ALL/Lymphoblastic Lymphoma LBL Following Hypersensitivity to E. coli-derived Asparaginases

Learn More

Phase 3

A phase 3 randomized trial for patients with de novo AML comparing standard therapy including gemtuzumab ozogamicin GO to CPX-351 with GO and the addition of the FLT3 inhibitor gilteritinib for patients with FLT3 mutations

Learn More

Phase 2

A PHASE II SINGLE-ARM STUDY OF TOTAL BODY IRRADIATION WITH LINAC BASED VOLUMETRIC MODULATED ARC THERAPY (VMAT) AND IMAGE GUIDED RADIATION THERAPY (IGRT)

Learn More

Phase 2

AAML18P1: Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia - Chronic Phase (CML-CP)

Learn More